Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile

  1. Díaz-Dinamarca, D.A.
  2. Díaz, P.
  3. Barra, G.
  4. Puentes, R.
  5. Arata, L.
  6. Grossolli, J.
  7. Riveros-Rodriguez, B.
  8. Ardiles, L.
  9. Santelises, J.
  10. Vasquez-Saez, V.
  11. Escobar, D.F.
  12. Soto, D.
  13. Canales, C.
  14. Díaz, J.
  15. Lamperti, L.
  16. Castillo, D.
  17. Urra, M.
  18. Zuñiga, F.
  19. Ormazabal, V.
  20. Nova-Lamperti, E.
  21. Benítez, R.
  22. Rivera, A.
  23. Cortes, C.P.
  24. Valenzuela, M.T.
  25. García-Escorza, H.E.
  26. Vasquez, A.E.
  27. Show all authors +
Journal:
Frontiers in Public Health

ISSN: 2296-2565

Year of publication: 2023

Volume: 11

Type: Article

DOI: 10.3389/FPUBH.2023.1229045 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus